PRESS RELEASE For immediate release Devonian Health Group Announces issuance of European Patent for its Purgenesis™ anti-aging treatment. Quebec, Quebec – July 31st, 2018 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage...
Press Releases
Devonian Health Group announces Non-Brokered Financing by way of a private placement of Convertible Debenture.
PRESS RELEASE For immediate release NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN THE UNITED STATES. Devonian Health Group announces Non-Brokered Financing by way of a private placement of Convertible Debenture. Aspri Pharma Canada Inc....
Devonian Healthcare Group Reports its First ever Revenues: Key Financial Results for Quarter Ended April 30th, 2018
PRESS RELEASE For immediate release Devonian Healthcare Group Reports its First ever Revenues: Key Financial Results for Quarter Ended April 30th, 2018 Quebec, Quebec – July 18, 2018 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a...
Devonian Announces Grant of Options
PRESS RELEASE For immediate release Devonian Announces Grant of Options. Quebec, Quebec - June 29th, 2018 – Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv: GSD) announces that the Board of Directors has approved the grant of options (the...
Devonian Announces the Signing of a Non-Binding Letter of Intent with Folia Biotech to develop FB-631 in cancer immunotherapy.
PRESS RELEASE For immediate release Devonian Announces the Signing of a Non-Binding Letter of Intent with Folia Biotech to develop FB-631 in cancer immunotherapy. Quebec, Quebec - June 28th, 2018 – Devonian Health Group Inc. ("Devonian" or the "Corporation")...
Devonian Health Group Announces issuance of United States Patent for its Purgenesis™ anti-aging treatment.
PRESS RELEASE For immediate release Devonian Health Group Announces issuance of United States Patent for its Purgenesis™ anti-aging treatment. Quebec, June 27th, 2018 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD)Devonian Health Group Inc....
Devonian Health Group announces the commercial launch of the Purgenesis™ Anti-aging treatment at the Canadian Dermatology Association’s annual conference
PRESS RELEASE For immediate release Devonian Health Group announces the commercial launch of the Purgenesis™ Anti-aging treatment at the Canadian Dermatology Association’s annual conference. First launch of the Purgenesis™ skin care line First and only product...
Purgenesis™: Commercializing a Skin-Care Revolution
READ MORE
Devonian Health Group Announces Canadian Patent for its Purgenesis™ anti-aging treatment
PRESS RELEASE For immediate release Devonian Health Group Announces Canadian Patent for its Purgenesis™ anti-aging treatment. Quebec - May 16th, 2018 – Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv: GSD) today announced that the Canadian...
Devonian Announces Grant of Options
PRESS RELEASE For immediate release Devonian Announces Grant of Options. QUEBEC, Québec - March 21st, 2018 – Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXv: GSD) announces that the Board of Directors has approved the grant of options (the...